Tri-Luma^® Cream is indicated for the short-term (8 week) treatment of moderate to severe melasma of the face. Tri-Luma^® Cream should be used with measures for sun avoidance, like using sunscreen of SPF 30 or higher. Tri-Luma^® Cream contains sulfites which may cause severe, life-threatening allergic reactions, so tell your doctor if you are allergic to sulfites. Tri-Luma^® Cream contains hydroquinone, which may cause a gradual blue-black darkening of the skin. If you are pregnant, nursing or trying to become pregnant you should not use Tri-Luma^® Cream. Safety and efficacy have not been established in individuals with darker skin. Reversible HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide, so discontinue use if signs or symptoms of this condition occur. In addition, redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided. Tri-Luma^® Cream should not be used with irritating products such as abrasive cleansers, scrubs, or skin-peeling agents.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. For more information about Tri-Luma^® Cream, please see full Prescribing Information.

Could it be melasma? Take the check test to get more information!

This melasma check test is only intended to serve as an awareness tool. If you think you have melasma, make an appointment with your doctor or dermatologist to discuss your concerns.

Share with a friend!

Do you currently have brown or gray-brown skin discoloration on your cheeks,
upper lip, nose, forehead or chin?
Select One Yes No

Are you:
Select One Female Male

What is your ethnicity?
Select One African-American Asian Caucasian Hispanic Native-American Pacific Islander Other

How many hours on average do you spend in direct sunlight each week?
Select One 0-2 2-10 10+

Do you consistently use a broad-spectrum sunscreen with SPF 30 or higher?
Select One Yes No

Do you expose your skin to extreme cold or heat or strong winds more than
2 hours a week?
Select One Yes No

IMPORTANT SAFETY INFORMATION

Tri-Luma^® Cream is indicated for the short-term (8 week) treatment of moderate to severe melasma of the face. Tri-Luma^® Cream should be used with measures for sun avoidance, like using sunscreen of SPF 30 or higher. Tri-Luma^® Cream contains sulfites which may cause severe, life-threatening allergic reactions, so tell your doctor if you are allergic to sulfites. Tri-Luma^® Cream contains hydroquinone, which may cause a gradual blue-black darkening of the skin. If you are pregnant, nursing or trying to become pregnant you should not use Tri-Luma^® Cream. Safety and efficacy have not been established in individuals with darker skin. Reversible HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide, so discontinue use if signs or symptoms of this condition occur. In addition, redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided. Tri-Luma^® Cream should not be used with irritating products such as abrasive cleansers, scrubs, or skin-peeling agents.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088. For more information about Tri-Luma^® Cream, please see full Prescribing Information.